Swamy Yeleswaram

Corporate Officer/Principal at RAPPORT THERAPEUTICS, INC.

Net worth: 10 M $ as of 2026-05-30

63 year

Consumer Services

Health Technology

Profile

Swamy Yeleswaram was the founder of Incyte Corp., founded in 2002, and held the title of Group Vice President-Drug Metabolism from 2016 to 2022.
Dr. Yeleswaram currently holds the position of Chief Development Officer at Rapport Therapeutics, Inc. since 2023.
Dr. Yeleswaram's education includes a doctorate from the University of British Columbia, a graduate degree from Banaras Hindu University, and an undergraduate degree from Madras Medical College.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
RAPPORT THERAPEUTICS, INC. 0.52%	2026-04-16	246,426 ( 0.52% )	10 M $	2026-05-30

Swamy Yeleswaram active positions

Companies	Position	Start
RAPPORT THERAPEUTICS, INC.	Corporate Officer/Principal	2022-12-31

All active positions of Swamy Yeleswaram

Former positions of Swamy Yeleswaram

Companies	Position	End
INCYTE CORPORATION	Founder	2022-07-31

See the detail of Swamy Yeleswaram's experience

Training of Swamy Yeleswaram

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Swamy Yeleswaram's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Incyte Corp. Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics	Health Technology
University of British Columbia University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Banaras Hindu University Banaras Hindu University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Madras Medical College Madras Medical College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Rapport Therapeutics, Inc. Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder	Health Technology